In pre-clinical literature and research peptide contexts, MT-1 and afamelanotide refer to the same compound
You can usually find their number on the back of your insurance card
No, its not saving lives, but if it improves quality of life, well, it can be cost-effective
Potential Benefits & Side Effects What the controlled human literature describes for the approved and investigational uses
The authors have reported that they have no relationships relevant to the contents of this paper to disclose
Empirical Health's heart health panel tracks ApoB, hs-CRP, glucose, kidney, liver, and nutrition markers over time, so you and your doctor can see what the drug is actually doing